<it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients

<p>Abstract</p> <p>Background</p> <p>A high incidence of rash has been reported in HIV-1 patients who received the anti-retroviral drug nevirapine. In addition, several studies have suggested that polymorphisms of human leukocyte antigen (<it>HLA</it>) genes...

Full description

Bibliographic Details
Main Authors: Tunthanathip Preecha, Prasithsirikul Wisit, Uttayamakul Sumonmal, Feangvad Siriluk, Rattanatham Tippawan, Likanonsakul Sirirat, Nakayama Emi E, Shioda Tatsuo
Format: Article
Language:English
Published: BMC 2009-10-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/6/1/22
_version_ 1819122906262667264
author Tunthanathip Preecha
Prasithsirikul Wisit
Uttayamakul Sumonmal
Feangvad Siriluk
Rattanatham Tippawan
Likanonsakul Sirirat
Nakayama Emi E
Shioda Tatsuo
author_facet Tunthanathip Preecha
Prasithsirikul Wisit
Uttayamakul Sumonmal
Feangvad Siriluk
Rattanatham Tippawan
Likanonsakul Sirirat
Nakayama Emi E
Shioda Tatsuo
author_sort Tunthanathip Preecha
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>A high incidence of rash has been reported in HIV-1 patients who received the anti-retroviral drug nevirapine. In addition, several studies have suggested that polymorphisms of human leukocyte antigen (<it>HLA</it>) genes may play important roles in nevirapine-induced rash. The aim of the present study was to evaluate the effects of different <it>HLA-C </it>alleles on rash associated with nevirapine in patients who started highly active anti-retroviral therapy (HAART) containing nevirapine in Thailand.</p> <p>Results</p> <p>A case-control study was carried out involving HIV-1 patients under treatment at Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand between March 2007 and March 2008. The study included all HIV/AIDS patients being treated with nevirapine-containing regimens. The study population comprised 287 HIV/AIDS patients of whom 248 were nevirapine-tolerant and 39 developed rash after nevirapine treatment. From the nevirapine-tolerant patients, 60 were selected as the control group on the basis of age, sex, and therapy history matched for nevirapine-induced rash cases. We observed significantly more <it>HLA-Cw*04 </it>alleles in nevirapine-induced rash cases than in nevirapine-tolerant group, with frequencies of 20.51% and 7.50%, respectively (P = 0.009). There were no significant differences between the rash and tolerant groups for other <it>HLA-C </it>alleles except for <it>HLA-Cw*03 </it>(P = 0.015).</p> <p>Conclusion</p> <p>This study suggests that <it>HLA-Cw*04 </it>is associated with rash in nevirapine treated Thais. Future screening of patients' <it>HLA </it>may reduce the number of nevirapine-induced rash cases, and patients with alleles associated with nevirapine-induced rash should be started on anti-retroviral therapy without nevirapine.</p>
first_indexed 2024-12-22T06:59:54Z
format Article
id doaj.art-2e6894df86be4be79623b5d5c64003ca
institution Directory Open Access Journal
issn 1742-6405
language English
last_indexed 2024-12-22T06:59:54Z
publishDate 2009-10-01
publisher BMC
record_format Article
series AIDS Research and Therapy
spelling doaj.art-2e6894df86be4be79623b5d5c64003ca2022-12-21T18:34:50ZengBMCAIDS Research and Therapy1742-64052009-10-01612210.1186/1742-6405-6-22<it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patientsTunthanathip PreechaPrasithsirikul WisitUttayamakul SumonmalFeangvad SirilukRattanatham TippawanLikanonsakul SiriratNakayama Emi EShioda Tatsuo<p>Abstract</p> <p>Background</p> <p>A high incidence of rash has been reported in HIV-1 patients who received the anti-retroviral drug nevirapine. In addition, several studies have suggested that polymorphisms of human leukocyte antigen (<it>HLA</it>) genes may play important roles in nevirapine-induced rash. The aim of the present study was to evaluate the effects of different <it>HLA-C </it>alleles on rash associated with nevirapine in patients who started highly active anti-retroviral therapy (HAART) containing nevirapine in Thailand.</p> <p>Results</p> <p>A case-control study was carried out involving HIV-1 patients under treatment at Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand between March 2007 and March 2008. The study included all HIV/AIDS patients being treated with nevirapine-containing regimens. The study population comprised 287 HIV/AIDS patients of whom 248 were nevirapine-tolerant and 39 developed rash after nevirapine treatment. From the nevirapine-tolerant patients, 60 were selected as the control group on the basis of age, sex, and therapy history matched for nevirapine-induced rash cases. We observed significantly more <it>HLA-Cw*04 </it>alleles in nevirapine-induced rash cases than in nevirapine-tolerant group, with frequencies of 20.51% and 7.50%, respectively (P = 0.009). There were no significant differences between the rash and tolerant groups for other <it>HLA-C </it>alleles except for <it>HLA-Cw*03 </it>(P = 0.015).</p> <p>Conclusion</p> <p>This study suggests that <it>HLA-Cw*04 </it>is associated with rash in nevirapine treated Thais. Future screening of patients' <it>HLA </it>may reduce the number of nevirapine-induced rash cases, and patients with alleles associated with nevirapine-induced rash should be started on anti-retroviral therapy without nevirapine.</p>http://www.aidsrestherapy.com/content/6/1/22
spellingShingle Tunthanathip Preecha
Prasithsirikul Wisit
Uttayamakul Sumonmal
Feangvad Siriluk
Rattanatham Tippawan
Likanonsakul Sirirat
Nakayama Emi E
Shioda Tatsuo
<it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients
AIDS Research and Therapy
title <it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients
title_full <it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients
title_fullStr <it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients
title_full_unstemmed <it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients
title_short <it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients
title_sort it hla cw 04 it allele associated with nevirapine induced rash in hiv infected thai patients
url http://www.aidsrestherapy.com/content/6/1/22
work_keys_str_mv AT tunthanathippreecha ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients
AT prasithsirikulwisit ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients
AT uttayamakulsumonmal ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients
AT feangvadsiriluk ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients
AT rattanathamtippawan ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients
AT likanonsakulsirirat ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients
AT nakayamaemie ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients
AT shiodatatsuo ithlacw04italleleassociatedwithnevirapineinducedrashinhivinfectedthaipatients